Table 3.
Description of the 18 Subjects With Falsely Benign Thyroid Nodules
| Age, y | Gender | Initial Nodule Size, cm | Nodule Size at Time of Surgery, cm | Reason for Removal | Time From Initial Benign FNA to Surgical Removal, y | Final Pathology | AJCC Staginga | Clinical Status | Total Follow-Up Time From Initial Benign FNA, y | |
|---|---|---|---|---|---|---|---|---|---|---|
| Subject number | ||||||||||
| 1 | 34 | Female | 2.0 | 1.9 | Abnormal repeat cytology | 5.4 | Papillary carcinoma | T1bN0M0 | Alive with no recurrence | 16.7 |
| 2 | 61 | Female | 2.2 | 2.7 | Abnormal repeat cytology | 4.0 | Papillary carcinoma | T2N0M0 | Alive with no recurrence | 10.1 |
| 3 | 38 | Female | 2.0 | 2.3 | Abnormal repeat cytology | 6.5 | Papillary carcinoma | T3N0M0 | Alive with no recurrence | 11.4 |
| 4 | 48 | Female | 1.5 | 1.6 | Abnormal repeat cytology | 7.3 | Follicular carcinoma | T1N0M0 | Alive with no recurrence | 7.4 |
| 5 | 49 | Female | 3.5 | 3.7 | Abnormal repeat cytology | 3.4 | Poorly differentiated carcinoma | T4bN0M0 | Alive with no recurrence | 16.3 |
| 6 | 52 | Female | 2.3 | 2.8 | Abnormal repeat cytology | 6.6 | Papillary carcinoma | T1N0M0 | Alive with no recurrence | 16.9 |
| 7 | 41 | Female | 2.0 | 2.2 | Abnormal repeat cytology | 2.4 | Papillary carcinoma | T1N0M0 | Alive with no recurrence | 2.4 |
| 8 | 51 | Female | 2.4 | 3.8 | Abnormal repeat cytology | 2.0 | Papillary carcinoma | T2N0M0 | Alive with no recurrence | 13.8 |
| 9 | 64 | Female | 3.4 | 4.0 | Abnormal repeat cytology | 1.8 | Papillary carcinoma | T2M0N0 | Alive with no recurrence | 9.9 |
| 10 | 54 | Female | 1.2 | 1.6 | Abnormal repeat cytology | 10.0 | Papillary carcinoma | T1N0M0 | Alive with no recurrence | 17.1 |
| 11 | 50 | Female | 3.0 | 3.9 | Abnormal repeat cytology | 9.8 | Papillary carcinoma | T3N0M0 | Alive with no recurrence | 17.7 |
| 12 | 24 | Female | 2.9 | 4.3 | Compressive symptoms | 2.0 | Papillary carcinoma | T2N0M0 | Alive with no recurrence | 7.1 |
| 13 | 41 | Female | 1.9 | 3.4 | Compressive symptoms | 5.9 | Papillary carcinoma | T3N0M0 | Alive with no recurrence | 8.7 |
| 14 | 61 | Female | 3.0 | 3.0 | Abnormal cytology in separate nodule | 3.2 | Papillary carcinoma | T2N0M0a | Alive with no recurrence | 10.3 |
| 15 | 23 | Female | 4.2 | 3.0 | Compressive symptoms | 0.3 | Papillary carcinoma | T2N0M0 | Alive with no recurrence | 1.0 |
| 16 | 45 | Female | 1.3 | 1.5 | Abnormal cytology in separate nodule | 3.0 | Papillary carcinoma | T1bN0M0a | Alive with no recurrence | 10.7 |
| 17 | 66 | Male | 1.3 | 1.9 | Abnormal cytology in separate nodule | 1.6 | Papillary carcinoma | T4aN0M0a | Alive with no recurrence | 10.3 |
| 18 | 54 | Female | 3.2 | 3.2 | Compressive symptoms | 6.2 | Papillary carcinoma | T2N0M0 | Alive with no recurrence | 11.3 |
Abbreviation: AJCC, American Joint Committee on Cancer.
a
Staging representative of entire thyroid cancer, including the separate nodule prompting FNA.